STAT+: CVS’s new drug payment plan won’t lower patients’ prices, experts warn
CVS Health is promising to simplify how its pharmacies get paid for drugs. But that…
Category: policy
STAT+: Senate panel considers Medicare policy fixes to drug shortages
WASHINGTON — Members of the Senate Finance Committee took their first steps today toward using…
Carmot’s chance of beating the odds in the biotech market just ended
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: BIO selects rare disease advocate, biotech executive John Crowley as new CEO
WASHINGTON — The Biotechnology Innovation Organization has chosen longtime biotech executive and rare disease advocate John…
STAT+: Cancer drug shortages won’t get better under Biden’s latest plan
WASHINGTON — President Biden’s new plan to curb drug shortages by boosting domestic drug production…
STAT+: Official: FDA needs staff influx to meet gene therapy needs
WASHINGTON — The Food and Drug Administration needs dozens more reviewers if it wants its…
Sweeping bill to fight opioid addiction will be considered by Senate health committee
The Senate health care committee will consider a sweeping bill next week meant to combat…
STAT Morning Rounds: Six health news stories you need to start your day
Understand how science, health policy, and medicine shape the world everyday. Sign up for our…
STAT+: Senate Republicans throw cold water on so-called site-neutral hospital pay cuts
WASHINGTON — On its face, a minor policy to make sure Medicare pays hospitals the…
CDC Director Mandy Cohen unscathed in her first congressional testimony
WASHINGTON — House Republicans sought Thursday to hammer the Centers for Disease Control and Prevention’s…
STAT+: Biden defends Trump-era drug pricing rule on copay accumulators
WASHINGTON — The Biden administration is appealing a court ruling against a Trump-era regulation that…
STAT+: FDA chief scientist to replace Woodcock
WASHINGTON — The Food and Drug Administration’s chief scientist will replace retiring Janet Woodcock as principal…
STAT+: Colon cancer prevention paradox: Higher-risk patients pay more for colonoscopy
Ashley Conway-Anderson was prepared for a lot of things when it came to her first…
STAT+: White House official dings Bristol-Myers Squibb for fighting off generic competition
WASHINGTON — A top White House official on Tuesday delivered a pointed attack at a…
STAT+: Scott Gottlieb, Trump FDA chief, questions whether there’s a Republican philosophy on health care
WASHINGTON — One of the Republican party’s most prominent health care thinkers doesn’t know what…
STAT+: Biden invokes Cold War-era law to stem drug shortages
WASHINGTON — President Biden is using a Cold War-era law to stem drug shortages by…
STAT+: House Republicans call CDC director to testify
WASHINGTON — A House committee that has sparred with the Biden administration over its handling…
STAT+: Prominent pharmaceutical industry ally Anna Eshoo to retire
WASHINGTON — Rep. Anna Eshoo, one of the House of Representatives’ top Democrats on health…
STAT+: Sen. Bernie Sanders publicly pressures Merck, J&J, and Bristol Myers Squibb to testify on drug pricing
WASHINGTON — Senate Democrats, led by Sen. Bernie Sanders (I-Vt.) on Tuesday mounted a public…
STAT+: Delay of eye drop recall highlights FDA’s impotence on the issue
WASHINGTON — It took nearly three weeks for a maker of eye drops to recall…
STAT+: U.K., pharma industry strike deal for how the NHS pays for medicines
LONDON — The U.K. and the pharmaceutical industry have reached a deal on a five-year…
STAT+: Biden appoints Vanderbilt oncologist to head National Cancer Institute
WASHINGTON — President Biden on Friday said he plans to appoint cancer researcher and doctor…
STAT+: Doctors divide over reforming a secretive panel that determines their Medicare pay
WASHINGTON — Doctors are splitting, specialty by specialty, over whether and how to overhaul a…
STAT+: FDA’s Janet Woodcock to retire early next year
WASHINGTON — Principal Deputy FDA Commissioner Janet Woodcock will retire early next year from the…
STAT+: House panel passes PBM reforms, ratcheting up chance for passage
WASHINGTON — Panels in both the House and Senate have now passed restrictions to drug…
STAT+: FDA’s latest reorganization puts a new emphasis on its investigations
WASHINGTON — There’s about to be a new acronym in town. The Food and Drug…
STAT+: House moves to limit so-called gain-of-function research
WASHINGTON — House lawmakers late Tuesday voted to attach a U.S. ban on controversial infectious…
STAT+: To get things done fast at FDA: ‘Don’t tell anybody,’ cancer chief says
WASHINGTON — The Food and Drug Administration’s top cancer drug regulator doesn’t always ask for…
What health policies could hitch a ride on a spending bill?
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…
AMA urges coverage of obesity treatments as payers balk at costs
WASHINGTON – The American Medical Association called on insurance companies, employers, and government programs to…
STAT+: Medicare’s new pay boost for primary care is angering specialists
WASHINGTON — Doctors are staring down a cut to their Medicare pay next year, and…
Medicare eligibility is tripping up the GOP presidential candidates
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…
Eli Lilly tries a rare tactic: competing on price
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Senator floats new models to manage costs of weight loss drugs like Ozempic
WASHINGTON — With Novo Nordisk’s Wegovy and Ozempic hitting blockbuster sales and a new rival…
Republicans divided over financial crisis in Medicare
WASHINGTON — Republicans angling for the party’s presidential nomination on Wednesday grappled with the reality…
STAT+: Senate panel clears PBM reforms, safety-net hospital payments
WASHINGTON — A prominent Senate panel on Wednesday passed a new package of health policy…
Senate confirms NIH Director Monica Bertagnolli
Longtime cancer doctor Monica Bertagnolli is finally heading to the National Institutes of Health director’s…
Sen. Bernie Sanders moves toward another hearing with pharma CEOs
You’re reading the web edition of D.C. Diagnosis. Sign up here to receive this newsletter in your…
.jpg)
STAT+: Drug shortages and the supply chain are a matter of national security, experts say
WASHINGTON – The pandemic showed how fragile the supply chain can be, and to fix…
STAT+: Government looks to tinker with new caps on Medicare Advantage broker payments
The federal government is proposing to rein in health insurance companies that entice brokers with…
STAT+: Medicare moves ahead with more price transparency requirements for hospitals
The federal government is moving forward with a spate of proposals that will force hospitals…
STAT+: Democrats push government to police algorithms in Medicare Advantage
House Democrats are raising concerns with the Biden administration that Medicare Advantage plans need better…
Shrinking COVID vaccine sales has Moderna course-correcting
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Medicare proceeds with plan to claw back hospital funds after Supreme Court decision
WASHINGTON — Medicare officials are moving forward with a plan to claw back money from certain…
STAT+: Key Senate panel to consider PBM, drug pricing reform package
WASHINGTON — A key Senate panel announced it will consider more policies to regulate pharmacy…
STAT+: For hospitals after No Surprises Act, physician subsidies are ‘the new contract labor’
Physician staffing firms, flailing in the wake of a federal law banning surprise bills, are…
Senate committee plans Nov. 8 vote on wide-ranging health care package
WASHINGTON — The Senate Finance Committee plans to vote Nov. 8 on legislation that includes…
Regeneron gene therapy improves hearing in child
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Europe takes steps to head off drug shortages, even as U.S. proposals stall
European drug regulators are updating regulations to stem drug shortages. Are there lessons for Americans?…
STAT+: Pharmacists can make shortage drugs, but at what cost?
Pharmacists increasingly are being asked to make drugs in bulk for hospitals that are in…